New Deal Advisors supports Evident (Bain Capital) in the acquisition of CrestOptics
Milan, october 6, 2026 – New Deal Advisors, an independent firm specialising in advisory services to M&A Transactions, has supported Evident, a portfolio company of Bain Capital, in the acquisition of CrestOptics S.p.A.
Based in Rome, CrestOptics has been in active operation since 2011 and specialises in the development and manufacture of advanced optical imaging systems for spinning-disc confocal microscopy and structured illumination microscopy (SIM), which can be integrated with the microscope platforms of leading global manufacturers. The acquisition extends Evident’s portfolio of imaging solutions for the life sciences and strengthens its capabilities in high-speed, high-information-content 3D imaging for research, pharmaceutical and biotechnology applications.
New Deal Advisors, with a team led by Antonio Ficetti Gasco (partner), provided financial due diligence services, to Evident.
***
New Deal Advisors is an independent firm specialising in advisory services in M&A. Established in 2012, New Deal Advisors provides support in a broad variety of extraordinary transactions streams including mergers and acquisitions, restructuring, transformation processes, forensic and litigation activities, fairness opinions and valuation services. New Deal Advisors has worked for more than a decade alongside private equity funds, investment holdings, family offices, financial institutions and strategic players achieving to date the finalisation of over 200 deals.